ARTA
A.R.T. Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-16,130
| Closed | -$77K | – | 94 |
|
|
2020
Q2 | $77K | Buy |
16,130
+3,100
| +24% | +$14.8K | 0.12% | 208 |
|
|
2020
Q1 | $26K | Buy |
+13,030
| New | +$26K | 0.46% | 25 |
|
|
2019
Q4 | – | Sell |
-104,930
| Closed | -$301K | – | 1334 |
|
|
2019
Q3 | $301K | Sell |
104,930
-12,600
| -11% | -$36.1K | 0.02% | 1047 |
|
|
2019
Q2 | $445K | Buy |
117,530
+34,300
| +41% | +$130K | 0.03% | 790 |
|
|
2019
Q1 | $677K | Buy |
+83,230
| New | +$677K | 0.04% | 636 |
|
|
2018
Q1 | – | Sell |
-16,452
| Closed | -$80K | – | 1496 |
|
|
2017
Q4 | $80K | Sell |
16,452
-239,214
| -94% | -$1.16M | ﹤0.01% | 1271 |
|
|
2017
Q3 | $1.34M | Sell |
255,666
-51,950
| -17% | -$272K | 0.07% | 413 |
|
|
2017
Q2 | $1.71M | Buy |
+307,616
| New | +$1.71M | 0.09% | 314 |
|
|
2017
Q1 | – | Sell |
-14,300
| Closed | -$90K | – | 1431 |
|
|
2016
Q4 | $90K | Buy |
+14,300
| New | +$90K | 0.01% | 1162 |
|
|
2016
Q2 | – | Sell |
-418,308
| Closed | -$1.18M | – | 1364 |
|
|
2016
Q1 | $1.18M | Buy |
418,308
+339,688
| +432% | +$961K | 0.05% | 517 |
|
|
2015
Q4 | $811K | Buy |
78,620
+13,995
| +22% | +$144K | 0.04% | 660 |
|
|
2015
Q3 | $736K | Buy |
+64,625
| New | +$736K | 0.03% | 736 |
|
|
2015
Q2 | – | Sell |
-242,149
| Closed | -$2.19M | – | 1478 |
|
|
2015
Q1 | $2.19M | Buy |
+242,149
| New | +$2.19M | 0.08% | 366 |
|
|
2014
Q4 | – | Sell |
-143,281
| Closed | -$1.4M | – | 1419 |
|
|
2014
Q3 | $1.4M | Buy |
143,281
+35,417
| +33% | +$346K | 0.06% | 410 |
|
|
2014
Q2 | $1.38M | Buy |
107,864
+7,625
| +8% | +$97.2K | 0.07% | 395 |
|
|
2014
Q1 | $1.06M | Buy |
+100,239
| New | +$1.06M | 0.06% | 476 |
|